Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.32 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.32 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5009150 | 0.80 | HSD17B10 (0.41) | TSHRCYP3A4PLA2G2CALDH1A1 | |
| SCHEMBL10711245 | 0.75 | CA1 (0.35) | CA1CA2 | |
| SCHEMBL309703 | 0.75 | CETP (0.36) | ALDH1A1 | |
| SCHEMBL309704 | 0.75 | CETP (0.36) | ALDH1A1 | |
| SCHEMBL9936988 | 0.73 | TSHR (0.37) | TSHRCA12CA1CA2CA9 | |
| SCHEMBL5008326 | 0.70 | TSHR (0.38) | TSHRALDH1A1 | |
| SCHEMBL24400257 | 0.70 | TSHR (0.33) | TSHRABCB11CYP3A4ADRA2BOPRD1 | |
| SCHEMBL21148406 | 0.70 | TSHR (0.33) | TSHRABCB11CYP3A4ADRA2BOPRD1 | |
| SCHEMBL21148174 | 0.70 | TSHR (0.33) | TSHRABCB11CYP3A4ADRA2BOPRD1 | |
| SCHEMBL21556176 | 0.70 | TSHR (0.33) | TSHRABCB11CYP3A4ADRA2BOPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1637514-B1 | METHOD FOR PRODUCING FLUORINE-CONTAINING ACRYLATE | TOSOH F TECH INC (JP) | 2014-05-07 | — | — | EP | disclosed |
| US-7470808-B2 | Method for producing fluorine-containing acrylate | TOSOH F-TECH, INC. (JP) | 2008-12-30 | — | — | US | disclosed |
| US-7470808-B2 | Method for producing fluorine-containing acrylate | TOSOH F-TECH, INC. (JP) | 2008-12-30 | — | — | US | disclosed |
| US-20060122423-A1 | Method for producing fluorine-containing acrylate | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 2006-06-08 | — | — | US | disclosed |
| EP-1637514-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING ACRYLATE | Tosoh F-Tech, Inc. (JP) | 2006-03-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060122423-A1 | Method for producing fluorine-containing acrylate | AFF4, CBR1, AFF1 | TSHR 52/4885ABCB11 806/4885CYP3A4 153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.